PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 21, 2024CancerOpen Access

Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple‐negative breast cancer: Results from the triple‐negative breast cancer cohort of the phase 2 LEAP‐005 Study

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHyun Cheol ChungESEsma Saada‐BouzidFLFederico Longo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chung et al. (2024) studied this question.

synapsesocial.com/papers/68e63c18b6db6435875ce008https://doi.org/10.1002/cncr.35387
View Full Paper
Ask AI
Bookmark
Share